It is no surprise that the world needs more health workers. In fact, even though there are currently 22 million nurses and 2 million midwives globally there is an urgent need for 18 million more health workers in order to reach universal health care coverage by 2030 according to the World Health Organization.
There is a particular need for 9 million nurses and midwives as they are critical components to a robust health system and are often on the front lines of general and critical care including:
Continue reading 2020 Marks The International Year of The Nurse and The Midwife #SupportNursesAndMidwives
- Prevention, diagnosis, and treatment of HIV, tuberculosis, malaria and other communicable diseases
- Prevention, diagnosis and treatment of noncommunicable diseases
- Sexual and reproductive health services, including family planning, and maternal and newborn health care, including immunization and breastfeeding support.
As I have written many times before postpartum hemorrhage (PPH) or excessive uterine bleeding after childbirth is the leading cause of maternal mortality in low-and-middle income countries. The recommended drug to prevent PPH according to the World Health Organization (WHO) is oxytocin. When administered in its recommended dose it causes little to no side effects. Oxytocin, the WHO’s current gold standard therapy, however, must be refrigerated and administered by skilled health workers posing two obstacles to its wider use in low resource, tropical settings.
Some countries have approved misoprostol, an oral drug, to prevent PPH, but there are several concerns that its use can be misappropriated for abortions instead of used solely for PPH. The World Health Organization has listed misoprostol as an alternative to oxytocin if it is not available.
Now, another PPH preventative drug, carbetocin, has been added to the latest updated 2019 WHO Essential Medicines List. The announcement was made last week. Unlike oxytocin, even at high temperatures carbetocin remains effective. The recommendation is that carbetocin can be used when oxytocin is not available or if its quality is uncertain. Additionally, the cost must be comparable to oxytocin.
Continue reading NEW: Drug That Prevents PostPartum Hemorrhage Added To WHO Essential Medicines List
Yesterday global women’s and children’s advocates sounded the alarm regarding alleged strong-arming by US delegates at this year’s World Health Assembly (WHA) in Geneva. The issue at hand was the rights of women regarding their choice between breastfeeding and formula feeding.
According to the New York Times, the US delegation sought to remove the language in a pro-breastfeeding resolution that compelled countries to “protect, promote and support breastfeeding” and to remove any restrictions on formula that many global health experts contend is harmful to infants and toddlers.
The US delegation threatened Ecuador (the sponsoring country for the resolution) with devasting trade measures and a reduction in military aid. Ecuador acquiesced as did many more African and Latin American countries until Russia stepped up to sponsor the resolution, a country the US could not threaten.
Lucy M. Sullivan, Executive Director of 1000 Days, tweeted an entire thread about what was happening at the World Health Assembly in May.
Continue reading Is the Formula Industry Overpowering Breastfeeding?
Anja Smith, Stellenbosch University
South Africa has extremely high maternal mortality levels. This is true when compared with developed countries as well as other developing countries.
According to the World Health Organisation, for every 100,000 live births in the country in 2015, 138 women died due to pregnancy and childbirth complications. In Sweden, fewer than five women die for every 100,000 live births. In Brazil, the estimate is 44 women for every 100,000 live births.
Continue reading Why Mothers Aren’t Accessing Antenatal Care Early in Their Pregnancies